Prokidney PROK
NASDAQ PROK
$1.63 +0.02 (+1.24%)
At close: Sep 29, 2026 · 4:00 PM EDT

Prokidney (PROK) Capital Expenditures (2021 - 2026)

Updated

Prokidney (PROK) reported Capital Expenditures of $3.83 million for Q2 2026, up 23.2% from $3.11 million a year earlier and up 1.3% from the prior quarter.

Analysis

Prokidney (PROK) Capital Expenditures (2021 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Prokidney's Capital Expenditures came in at $18.57 million, down 42.3% year-over-year; for FY2025, it came in at $15.2 million, down 48.5% from FY2024.

  • Capital Expenditures has a five-year compound annual growth rate of 22.7% (FY2020 to FY2025).
  • By year, Capital Expenditures came in at $29.51 million in FY2024 (-13.7%), $34.2 million in FY2023, $1.85 million in FY2022 (-64.4%) and $5.19 million in FY2021 (-4.8%).
  • Five-year quarterly Capital Expenditures spans a low of $306,000 in Q4 2022 and a high of $27.94 million in Q3 2023.
  • Year over year, Capital Expenditures gained in five of the last seven quarters, with growth averaging 87.4%.
  • The high point for year-over-year Capital Expenditures in five years was Q2 2023 (growth of 858.5%); the low point was Q3 2024 (a decline of 91.4%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $3.79 million (Q1 2026), $5.75 million (Q4 2025) and $5.2 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 1.32 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 322.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -763.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 112.20 Mn
10 Prokidney 823.10 Mn 1.93 Bn - 3.83 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.83 Mn
Mar 31, 2026 3.79 Mn
Dec 31, 2025 5.75 Mn
Sep 30, 2025 5.20 Mn
Jun 30, 2025 3.11 Mn
Mar 31, 2025 1.14 Mn
Dec 31, 2024 25.51 Mn
Sep 30, 2024 2.40 Mn
Jun 30, 2024 636,000.00
Mar 31, 2024 960,000.00
Dec 31, 2023 1.57 Mn
Sep 30, 2023 27.94 Mn
Jun 30, 2023 3.70 Mn
Mar 31, 2023 986,000.00
Dec 31, 2022 306,000.00
Sep 30, 2022 315,000.00
Jun 30, 2022 386,000.00
Mar 31, 2022 839,000.00
Dec 31, 2021 540,000.00
API Access

Prokidney Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PROK&period=max&api_key=YOUR_API_KEY